|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Healthy | |||||
| 2 | Interventions listed in this trial | ||||
| 1064 nm Nd:YAG laser | |||||
| Imiquimod, 5% cream | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Imiquimod | |||||
| 4 | More general drug interventions related to this trial | ||||
| Adjuvants, Immunologic | |||||
| Antineoplastic Agents | |||||
| Immunologic Factors | |||||
| Interferon Inducers | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| University of Miami | |||||
| Graceway Pharmaceuticals, LLC | |||||